Published in PLoS One on July 08, 2013
Alkaline hydrolysis to remove potentially infectious viral RNA contaminants from DNA. Virol J (2016) 0.75
Comparative Analysis of Non-viral Transfection Methods in Mouse Embryonic Fibroblast Cells. J Biomol Tech (2017) 0.75
The alphaviruses: gene expression, replication, and evolution. Microbiol Rev (1994) 16.68
5'-Triphosphate RNA is the ligand for RIG-I. Science (2006) 15.78
Identification of host proteins required for HIV infection through a functional genomic screen. Science (2008) 12.44
Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe (2008) 6.24
In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release. J Virol (1991) 6.02
Genomic screening with RNAi: results and challenges. Annu Rev Biochem (2010) 3.08
Cytoplasmic structures associated with an arbovirus infection: loci of viral ribonucleic acid synthesis. J Virol (1968) 3.04
Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods (2004) 2.38
Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer. J Virol (1996) 2.01
Cell penetration by transportan. FASEB J (1998) 1.93
Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening. FASEB J (2009) 1.90
Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. FASEB J (2007) 1.71
Properly folded nonstructural polyprotein directs the semliki forest virus replication complex to the endosomal compartment. J Virol (2003) 1.52
Phosphatidylinositol 3-kinase-, actin-, and microtubule-dependent transport of Semliki Forest Virus replication complexes from the plasma membrane to modified lysosomes. J Virol (2010) 1.52
Different types of nsP3-containing protein complexes in Sindbis virus-infected cells. J Virol (2008) 1.50
Semliki Forest virus nonstructural protein 2 is involved in suppression of the type I interferon response. J Virol (2007) 1.41
A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus. J Hepatol (2011) 1.41
Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo. Nucleic Acids Res (2011) 1.35
Type I interferon reaction to viral infection in interferon-competent, immortalized cell lines from the African fruit bat Eidolon helvum. PLoS One (2011) 1.23
Role of the amphipathic peptide of Semliki forest virus replicase protein nsP1 in membrane association and virus replication. J Virol (2006) 1.20
A plasmid-based self-amplifying Sindbis virus vector. Hum Gene Ther (1995) 1.19
PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response. J Gen Virol (2009) 1.18
Insertion of EGFP into the replicase gene of Semliki Forest virus results in a novel, genetically stable marker virus. J Gen Virol (2007) 1.09
Cationic polymers and their therapeutic potential. Chem Soc Rev (2012) 1.08
Non-viral amplification systems for gene transfer: vectors based on alphaviruses. Curr Opin Mol Ther (1999) 1.07
Alphavirus vectors for cancer therapy. Virus Res (2010) 1.06
Novel functions of the alphavirus nonstructural protein nsP3 C-terminal region. J Virol (2009) 1.05
Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo. Bioconjug Chem (2001) 1.04
The molecular pathogenesis of Semliki Forest virus: a model virus made useful? J Gen Virol (1999) 1.02
Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice. Vaccine (1999) 0.99
Development of hybrid viral vectors for gene therapy. Biotechnol Adv (2012) 0.97
Transfection of large plasmids in primary human myoblasts. Gene Ther (2001) 0.90
Arginine-rich cell-penetrating peptides deliver gene into living human cells. Gene (2012) 0.86
Use of cell-penetrating-peptides in oligonucleotide splice switching therapy. Curr Gene Ther (2012) 0.84
Novel viral vectors utilizing intron splice-switching to activate genome rescue, expression and replication in targeted cells. Virol J (2011) 0.79
Application of PepFect peptides for the delivery of splice-correcting oligonucleotides. Methods Mol Biol (2011) 0.78
Semliki Forest virus vectors for gene therapy. Expert Opin Biol Ther (2003) 0.78
Phenoloxidase activity acts as a mosquito innate immune response against infection with Semliki Forest virus. PLoS Pathog (2012) 1.69
Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T. Neuroimage (2013) 1.58
Properly folded nonstructural polyprotein directs the semliki forest virus replication complex to the endosomal compartment. J Virol (2003) 1.52
Cell-penetrating peptides: design, synthesis, and applications. ACS Nano (2014) 1.52
Polypurine (A)-rich sequences promote cross-kingdom conservation of internal ribosome entry. Proc Natl Acad Sci U S A (2002) 1.45
Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays. PLoS One (2011) 1.37
Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo. Nucleic Acids Res (2011) 1.35
Regulation of the sequential processing of Semliki Forest virus replicase polyprotein. J Biol Chem (2003) 1.34
A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice. J Immunol (2012) 1.27
Penetration without cells: membrane translocation of cell-penetrating peptides in the model giant plasma membrane vesicles. J Control Release (2011) 1.26
Sequestration of G3BP coupled with efficient translation inhibits stress granules in Semliki Forest virus infection. Mol Biol Cell (2012) 1.22
Role of the amphipathic peptide of Semliki forest virus replicase protein nsP1 in membrane association and virus replication. J Virol (2006) 1.20
Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice. J Virol (2013) 1.19
Viperin restricts chikungunya virus replication and pathology. J Clin Invest (2012) 1.16
Complex formation between hepatitis C virus NS2 and NS3 proteins. Virus Res (2005) 1.14
A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy. J Control Release (2008) 1.10
Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptides. J Control Release (2011) 1.09
Insertion of EGFP into the replicase gene of Semliki Forest virus results in a novel, genetically stable marker virus. J Gen Virol (2007) 1.09
Molecular determinants of substrate specificity for Semliki Forest virus nonstructural protease. J Virol (2006) 1.07
Modulation of Aire regulates the expression of tissue-restricted antigens. Mol Immunol (2007) 1.07
Semliki forest virus-induced endoplasmic reticulum stress accelerates apoptotic death of mammalian cells. J Virol (2010) 1.07
Mutations in the nuclear localization signal of nsP2 influencing RNA synthesis, protein expression and cytotoxicity of Semliki Forest virus. J Gen Virol (2008) 1.05
Novel functions of the alphavirus nonstructural protein nsP3 C-terminal region. J Virol (2009) 1.05
Cell-to-cell spread of the RNA interference response suppresses Semliki Forest virus (SFV) infection of mosquito cell cultures and cannot be antagonized by SFV. J Virol (2009) 1.04
Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy. J Control Release (2009) 1.01
Cell-penetrating peptides for the delivery of nucleic acids. Expert Opin Drug Deliv (2012) 1.00
Therapeutics and vaccines against chikungunya virus. Vector Borne Zoonotic Dis (2015) 1.00
Apolar surface area determines the efficiency of translocon-mediated membrane-protein integration into the endoplasmic reticulum. Proc Natl Acad Sci U S A (2011) 0.99
Mutations at the palmitoylation site of non-structural protein nsP1 of Semliki Forest virus attenuate virus replication and cause accumulation of compensatory mutations. J Gen Virol (2007) 0.98
PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation. Nucleic Acids Res (2011) 0.97
Macromolecular assembly-driven processing of the 2/3 cleavage site in the alphavirus replicase polyprotein. J Virol (2011) 0.97
The structure of GFRalpha1 domain 3 reveals new insights into GDNF binding and RET activation. EMBO J (2004) 0.96
Chemically modified cell-penetrating peptides for the delivery of nucleic acids. Expert Opin Drug Deliv (2009) 0.96
A peptide-based vector for efficient gene transfer in vitro and in vivo. Mol Ther (2011) 0.95
Human protamine-1 as an MRI reporter gene based on chemical exchange. ACS Chem Biol (2013) 0.95
Construction, properties, and potential application of infectious plasmids containing Semliki Forest virus full-length cDNA with an inserted intron. J Virol Methods (2007) 0.92
Properties of non-structural protein 1 of Semliki Forest virus and its interference with virus replication. J Gen Virol (2008) 0.91
Functional cross-talk between distant domains of chikungunya virus non-structural protein 2 is decisive for its RNA-modulating activity. J Biol Chem (2014) 0.90
Magnetic fractionation and proteomic dissection of cellular organelles occupied by the late replication complexes of Semliki Forest virus. J Virol (2013) 0.89
RIG-I and MDA-5 detection of viral RNA-dependent RNA polymerase activity restricts positive-strand RNA virus replication. PLoS Pathog (2013) 0.88
Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo. Bioconjug Chem (2011) 0.84
Identification of mutations causing temperature-sensitive defects in Semliki Forest virus RNA synthesis. J Virol (2006) 0.84
Molecular defects caused by temperature-sensitive mutations in Semliki Forest virus nsP1. J Virol (2008) 0.84
Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout. Virol J (2013) 0.84
Retro-inversion of certain cell-penetrating peptides causes severe cellular toxicity. Biochim Biophys Acta (2010) 0.84
Neurons and oligodendrocytes in the mouse brain differ in their ability to replicate Semliki Forest virus. J Neurovirol (2008) 0.84
In vivo biodistribution and efficacy of peptide mediated delivery. Trends Pharmacol Sci (2010) 0.84
Cell-penetrating peptide secures an efficient endosomal escape of an intact cargo upon a brief photo-induction. Cell Mol Life Sci (2013) 0.83
New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids. Biochim Biophys Acta (2013) 0.83
Comparison of cAMP-dependent protein kinase substrate specificity in reaction with proteins and synthetic peptides. Biochim Biophys Acta (2004) 0.82
Properties and use of novel replication-competent vectors based on Semliki Forest virus. Virol J (2009) 0.82
The role of endocytosis on the uptake kinetics of luciferin-conjugated cell-penetrating peptides. Biochim Biophys Acta (2011) 0.82
Presentation overrides specificity: probing the plasticity of alphaviral proteolytic activity through mutational analysis. J Virol (2013) 0.82
Cell-penetrating peptides split into two groups based on modulation of intracellular calcium concentration. J Biol Chem (2012) 0.81
Mouse macrophage innate immune response to Chikungunya virus infection. Virol J (2012) 0.81
Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates. Bioconjug Chem (2010) 0.80
Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions. J Control Release (2012) 0.80
Novel vectors expressing anti-apoptotic protein Bcl-2 to study cell death in Semliki Forest virus-infected cells. Virus Res (2007) 0.79
Novel viral vectors utilizing intron splice-switching to activate genome rescue, expression and replication in targeted cells. Virol J (2011) 0.79
Inhibition of autophagy via p53-mediated disruption of ULK1 in a SCA7 polyglutamine disease model. J Mol Neurosci (2013) 0.79
Classes of Cell-Penetrating Peptides. Methods Mol Biol (2015) 0.78
Peptide-based vectors: recent developments. Biomol Concepts (2014) 0.78
Application of PepFect peptides for the delivery of splice-correcting oligonucleotides. Methods Mol Biol (2011) 0.78
CPP-Based Delivery System for In Vivo Gene Delivery. Methods Mol Biol (2015) 0.77
PepFect14 peptide vector for efficient gene delivery in cell cultures. Mol Pharm (2012) 0.77
Development of a novel nanoparticle by dual modification with the pluripotential cell-penetrating peptide PepFect6 for cellular uptake, endosomal escape, and decondensation of an siRNA core complex. Biopolymers (2013) 0.77
Cell-Penetrating Peptides. Preface. Methods Mol Biol (2015) 0.77
Intracellular translocation and differential accumulation of cell-penetrating peptides in bovine spermatozoa: evaluation of efficient delivery vectors that do not compromise human sperm motility. Hum Reprod (2013) 0.77
Novel systemically active galanin receptor 2 ligands in depression-like behavior. J Neurochem (2013) 0.77
The infection of mammalian and insect cells with SFV bearing nsP1 palmitoylation mutations. Virus Res (2010) 0.76
Porous tantalum and tantalum oxide nanoparticles for regenerative medicine. Acta Neurobiol Exp (Wars) (2014) 0.76
Application of CPPs for Brain Delivery. Methods Mol Biol (2015) 0.76
Fragment-based development of HCV protease inhibitors for the treatment of hepatitis C. Curr Comput Aided Drug Des (2012) 0.76
Peptide-based glioma-targeted drug delivery vector gHoPe2. Bioconjug Chem (2013) 0.75
Salicylic Acid Conjugated Dendrimers Are a Tunable, High Performance CEST MRI NanoPlatform. Nano Lett (2016) 0.75
Toxicity, Immunogenicity, Uptake, and Kinetics Methods for CPPs. Methods Mol Biol (2015) 0.75
Peptide nanoparticle delivery of charge-neutral splice-switching morpholino oligonucleotides. Nucleic Acid Ther (2015) 0.75
Control of the rescue and replication of Semliki Forest virus recombinants by the insertion of miRNA target sequences. PLoS One (2013) 0.75
Screening for the optimal specificity profile of protein kinase C using electrospray mass-spectrometry. J Biomol Screen (2005) 0.75
PepFects and NickFects for the Intracellular Delivery of Nucleic Acids. Methods Mol Biol (2015) 0.75
Sequence-defined oligoaminoamides for the delivery of siRNAs. Methods Mol Biol (2015) 0.75
SCARA Involvement in the Uptake of Nanoparticles Formed by Cell-Penetrating Peptides. Methods Mol Biol (2015) 0.75
Synthesis and biological activity of bimorpholine and its carbanucleoside. Nucleosides Nucleotides Nucleic Acids (2011) 0.75
The Antimicrobial and Antiviral Applications of Cell-Penetrating Peptides. Methods Mol Biol (2015) 0.75